APA (7th ed.) Citation

H, C., N, B., K, D., & J, I. (2026). Transdermal Buprenorphine Dosing Interval Optimization from 7 Days to 5 Days: A Case Series. Journal of pain & palliative care pharmacotherapy, 40(2), 369. https://doi.org/10.1080/15360288.2026.2653549

Chicago Style (17th ed.) Citation

H, Curtis, Bailey N, Dickey K, and Ineck J. "Transdermal Buprenorphine Dosing Interval Optimization from 7 Days to 5 Days: A Case Series." Journal of Pain & Palliative Care Pharmacotherapy 40, no. 2 (2026): 369. https://doi.org/10.1080/15360288.2026.2653549.

MLA (9th ed.) Citation

H, Curtis, et al. "Transdermal Buprenorphine Dosing Interval Optimization from 7 Days to 5 Days: A Case Series." Journal of Pain & Palliative Care Pharmacotherapy, vol. 40, no. 2, 2026, p. 369, https://doi.org/10.1080/15360288.2026.2653549.